$40 million is the valuation of a possible cure fo
Post# of 72436
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
Market cap of CTIX this morning is 157.76 million. 4 clinical trials for 3 drugs, for 4 completely different applications.
Meanwhile, companies with one drug that isn't anywhere as far along in clinical trials as CTIX is with its newest drug trials are valued absurdly higher. Look at AXON, with its market cap of 1.2 Billion. Their entire "company" has intellectual property consisting of a failed Alzheimer's drug, using the same mechanism of action as other failed Alzheimer's drug -- and hasn't even started a clinical trial. To be fair, their market value has declined from approximately 3 Billion at the IPO -- but this shows you how ludicrous the valuation of CTIX is here.
I'm probably going to buy more today.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)